ces in objective task difficulty that may influence the estimation of individual differences in stoprelated neural activity. This report examines the effect that these algorithm-related differences have on the measurement of neural activity during the stop signal task. We compared two groups of subjects (n 5 210) who differed in inhibitory ability using both a standard fMRI analysis and an analysis that resampled trials to remove the objective task difficulty confound. The results show that objective task difficulty influences the magnitude of between-group differences and that controlling for difficulty attenuates stop-related activity differences between superior and poor inhibitors. Specifically, group differences in the right inferior frontal gyrus, right middle occipital gyrus, and left inferior frontal gyrus are diminished when differences in objective task difficulty are controlled for. Also, when objective task difficulty effects are exaggerated, group differences in stop related activity emerge in other regions of the stopping network. The implications of these effects for how we interpret individual differences in activity levels are discussed.
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| IN TR ODUC TION
The ability to inhibit unwarranted behaviors and thoughts is considered a major component of executive functioning (Barkley, 1997) .
Inhibitory control is thought to be the central deficit in attention deficit hyperactivity disorder (ADHD; Casey et al. 1997; Quay 1997; Slaats-Willemse, Swaab-Barneveld, de Sonneville, van der Meulen, & Buitelaar, 2003) , and is also impaired in substance use disorders (Nigg et al., 2006; Whelan et al., 2012) and obsessive compulsive disorder (OCD; Penades et al., 2007) . In the laboratory, tasks examining aspects of motor response inhibition have been used to assess inhibitory control and identify impairments in this domain, and therefore it is critical that such tasks accurately describe inter-individual differences so that pathologies associated with impairments can be characterized appropriately.
The Stop Signal Task (SST; Logan & Cowan, 1984) has, to a large extent, been a hallmark assessment for inhibitory control in neuroimaging and neurophysiological research. The SST is composed of go and stop trials. On go trials, the participant must respond rapidly via a button press to a "go signal." However, on a minority of trials (stop trials; typically 20%-25% of trials), the go signal will be followed by a "stop signal," indicating that the individual should attempt to countermand the already initiated response.
On stop trials, the interval between the onset of the go signal and the onset of the stop signal is known as the stop signal delay (SSD), and this delay will determine the difficulty of successful inhibition.
If the SSD is short (i.e., the stop signal appears very soon after the go signal is presented) it is easier to inhibit the motor response, and if the SSD is long it is more difficult to inhibit the motor response (Logan, 1994) .
Often the SST employs an adaptive algorithm tracking procedure in which a participant's performance dictates the SSD of the subsequent stop trial to reach an SSD that elicits 50% stopping accuracy. In the tracking procedure, successful stopping results in a longer SSD in the following stop trial, which reduces the probability of successful inhibition, and unsuccessful stopping results in a shorter SSD in the following stop trial, which increases the probability of successful inhibition. By equating accuracy on stop trials across all participants at 50%, it is possible to quantitatively compare inhibitory abilities across participants. The tracking procedure allows for simple calculation of the Stop Signal Reaction Time (SSRT), or the time required to inhibit an already initiated motor response (Logan, Schachar, & Tannock, 1997) . The SSRT is an indirect measure of inhibitory ability and commonly used as the main outcome variable of the SST.
Numerous neuroimaging and neurophysiological studies have used the tracking SST to compare stop-related neural activity between groups of participants. The literature suggests that more impulsive responders (those with a longer SSRT) show decreased neural activity in key response inhibition regions of the brain. First, there is a sizeable behavioral literature suggesting individuals with ADHD perform poorly on the SST (for reviews, see Alderson, Rapport, & Kofler, 2007; Lijffijt, Kenemans, Verbaten, & van Engeland, 2005; Oosterlaan, Logan, & Sergeant, 1998) . Supplementing the behavioral studies on the SST and ADHD, fMRI studies have also found that individuals with ADHD performed worse compared to controls, as noted by longer SSRT, and this poor performance was associated with reduced activity in the right mesial frontal cortex, right inferior prefrontal cortex, and left caudate (Rubia et al., 1999; Rubia, Smith, Brammer, Toone, & Taylor, 2005) as well as the right pre-supplementary motor area, right dorsolateral prefrontal cortex, and right basal ganglia structures (Dickstein, Bannon, Xavier Castellanos, & Milham, 2006; Hart et al., 2014; Passarotti, Sweeney, & Pavuluri, 2010) during successful inhibition. Event-related potential (ERP) studies have yielded similar results, finding decreased right frontal N2 and P3 amplitudes during successful stopping in individuals with ADHD during the SST (Liotti, Pliszka, Perez, Kothmann, & Woldorff, 2005; Pliszka, Liotti, & Woldorff, 2000; Senderecka, Grabowska, Szewczyk, Gerc, & Chmylak, 2012) . Furthermore, this prefrontal and basal ganglia hypoactivity observed in individuals with ADHD is attributed to response inhibition deficits in ADHD, rather than attentional deficits (Cubillo et al., 2009; Dickstein et al., 2006; Hart, Radua, Nakao, Mataix-Cols, & Rubia, 2013 , Morien-Zamir et al., 2014 . These results indicate that a key feature of ADHD is poor performance on the SST, and, importantly, this is related to decreased activation of regions associated with response inhibition.
In research examining healthy participants, normal variation in SST performance has also been associated with different levels of neural activity. Multiple studies have reported significant negative correlations between SSRT and stop-related activity in key inhibitory control regions (Chikazoe et al., 2009; Chao, Luo, Chang, & Li, 2009; Congdon et al., 2010; Duann, Ide, Luo, & Li, 2009; Li, Huang, Constable, & Sinha, 2006; Li, Yan, Sinha, & Lee, 2008; Whelan et al., 2012) , suggesting that increased inhibitory ability is associated with increased neural activity, consistent with the clinical findings above. Aron and Poldrack (2006) found that stop-related activity in the right inferior frontal cortex correlated negatively with SSRT and, using a median split of SSRT to create two groups of participants, found increased activity in the right inferior frontal cortex in the faster SSRT group. These findings suggest that superior response inhibition performance, and therein superior inhibitory control, is associated with increased neural activity in regions associated with this executive function.
Despite the extensive literature demonstrating individual differences using the adaptive SST, there may be concerns with its suitability for determining inter-individual, and to some degree intra-individual, differences in neural activity. Although the tracking procedure is designed to elicit equal subjective task difficulty across participants (meaning all participants inhibit at 50% of stop trials), this results in unequal objective task difficulty across participants (meaning different participants reach 50% stopping accuracy at a range of SSDs). That is, individuals who differ on inhibitory abilities will ultimately complete different versions of the SST. When an individual with relatively superior inhibitory abilities completes the task, he/she will be able to successfully inhibit at longer, more difficult SSDs, and, subsequently, the adaptive algorithm will increase the SSDs to ensure 50% inhibition rate for that individual. In contrast, a relatively poor inhibitor will complete shorter, easier SSDs to ensure their 50% accuracy. This is potentially problematic, especially considering that as SSD increases, activation increases in various inhibitory regions. Aron and Poldrack (2006) found that SSD was positively correlated with activity in the right subthalamic nucleus, the right pre-supplementary motor area, and the right globus pallidus. Therefore, the increased activity observed in superior inhibitors may be due to the higher demands of a more objectively difficult version of the SST rather than reflecting an inherent characteristic of the activation levels of superior inhibitors.
Given the results from previous neuroimaging and neurophysiological work on the SST, it is difficult to discern if neural activation differences observed between superior inhibitors and poor inhibitors reflect differences in inherent inhibitory abilities, or reflect differences in objective task difficulty. This is of potential concern when considering the literature suggesting that a major deficit of ADHD is poor response inhibition coupled with hypo-activation and considering the multiple reports finding SSRT scores correlate negatively with neural activity.
The goal of the current study is to examine if group differences in stop-related activity are influenced by differences in objective task demands (i.e., the stop signal delay duration of successfully inhibited stop trials). To accomplish this, we compared two groups of individuals that were selected based on differences in SSRT scores while performing the SST during fMRI acquisition. We compared regional activity from the two groups in which subjective difficulty was equivalent (both groups perform at a similar successful inhibition rate) and in which objective difficulty was equivalent (both groups successfully inhibit an identical set of trials). We hypothesized that group differences in regional activity observed in the subjectively equal condition would be attenuated when groups were compared during the objectively equal condition.
| Participants
Neuroimaging data used in the current study were collected as part of the large, longitudinal neuroimaging study, IMAGEN (https://imageneurope.com). A description of participant recruiting procedures, assessment and data collection, and inclusion criteria has been previously described in Schumann et al (2010) . In the current study, we examined data from 210 participants collected during the second neuroimaging time point (mean age 5 18.96, SD 5 0.72). (Logan et al. 1997) . The goal of the tracking algorithm is to arrive at a 50% accuracy on stop trials for all participants. The initial stop trial SSD was 150 ms, and varied by 50 ms based on performance on the previous trial (increasing to make the next stop trial more difficult if the participant successfully inhibited on the previous stop trial and decreasing to make the next stop trial easier if the participant failed to successfully inhibit on the previous stop trial). The main performance measure of the SST, the Stop Signal Reaction Time (SSRT), was computed as described previously (Whelan et al., 2012) .
| The stop signal task
SSRT was computed by subtracting the median SSD of all successful stop trials from the nth percentile go reaction time, where n represents the percentage of successful inhibitions.
| Superior and poor inhibitors
The goal of the present study was to examine how the tracking algorithm influences inter-individual differences in stop-related activity, and therefore two groups of subjects were chosen that would best exhibit group differences. The two groups of participants, superior and poor inhibitors, were defined based on SSRT performance values derived from the SST. 725 participants who had stop task neuroimaging data that passed quality control for excessive motion (i.e., mean framewise displacement <0.9 mm as indicated by Siegel et al., 2014) were ranked based on their SSRT. Superior inhibitors were the top 20% of participants with the fastest SSRT values (mean SSRT 5 137 ms) and the poor inhibitors were the bottom 20% of participants with the slowest SSRT values (mean SSRT 5 250 ms), resulting in 125 participants in each group. Further task performance quality control was performed (in accordance with Congdon et al., 2012;  i.e., >50 ms SSRT, percent successful inhibition between 25% and 75%, less than 10% errors on go trials, and fewer than 10 stop trials in which the participant responded before the onset of the go signal). Finally, after dropping participants from the analysis to ensure equal sample sizes in the two groups, the final sample size contained 210 participants with 105 in each group.
| AllSSD, CommonSSD, and UncommonSSD
To examine the effects of objective task difficulty on inter-individual differences in stop-related activity, we compared superior and poor inhibitors on three different subtypes of trials. In the first analysis, the AllSSD condition, activation maps for each participant were generated using all successful stop trials, as is standard in the neuroimaging literature. Here, the two groups are participating at equal subjective task difficulty (all participants inhibiting on approximately 50% of stop trials), however the two groups were compared on a task that was objectively more difficult for the superior inhibitors (the superior inhibitors successfully inhibited on trials with longer SSDs; see Figure 1 ).
The goal of the second analysis, the CommonSSD condition, was to examine group differences on a subset of trials that were equal in objective task difficulty (shaded region, Figure 1 ). The CommonSSD condition contained an equal number of trials at each SSD for the two groups (Table 1) . To accomplish this, we randomly selected successful stop trials from each group so that both groups had the same number of successful stop trials at each SSD. Additionally, we matched the number of participants from each group that contributed to the analyses at each SSD (see Table 1 ). For example, at 250 ms SSD, there were 45 poor inhibitors that successfully inhibited on 120 stop trials in total and there were 101 superior inhibitors that successfully inhibited on 599 stop trials in total. To match these groups, we randomly selected 45 of the 101 superior inhibitors, and from the 45 selected participants, we randomly chose 120 successful stop trials. This procedure was conducted for SSDs of 50-500 ms. The trials that were not selected for the CommonSSD condition comprised the UncommonSSD condition (unshaded region, Figure 1 ); these trials maximize the SSD confound between the superior and poor participants. Therefore, the model for this analysis was identical to that of the AllSSD condition, except here all successful stop trials were assigned to either the CommonSSD or UncommonSSD trial types.
| AllSSD-subsample
The CommonSSD condition contains approximately half the number of trials used to generate activation contrasts in the AllSSD condition (48% of successful stop trials for the superior inhibitors and 53% of successful stop trials for the poor inhibitors; see Table 1 ). To control for the potential influence this loss of power may have when comparing results from the AllSSD to the CommonSSD condition, we created a third condition.
The AllSSD-subsample condition is composed of 50% of trials randomly selected from the AllSSD condition of each participant. In this manner, the AllSSD-subsample condition preserves the same group differences in the distribution of SSD length on successful stop trials as in the AllSSD condition, while also containing a similar number of trials used to generate activation contrasts as in the CommonSSD condition.
| fMRI acquisition and analysis
Full a full description of the MRI acquisition, quality control procedures, and multi-site standardization please refer to Schumann et al. (2010) . included as nuisance variables. Regressors modeling the experimental conditions are convolved using SPM's default hemodynamic response function. Task condition regressors include stop success trials (more details below), stop failure trials, trials on which the go response was too late and trials on which the go response was wrong (if any). Contrast images are generated for successful (stop success) responses against the implicit baseline of the go success condition while removing variance associated with the other regressors in the design matrix, as this has been the model used previously on the IMAGEN dataset (Whelan et al., 2012) . For all contrast images, intensity in each voxel represents the estimated percent BOLD signal change associated with the regressor.
Three different design matrices were used in the current study to create activation contrasts for successful stop trials. The three design matrices were identical except for how successful stop trials were modeled. For the AllSSD condition, all successful stop trials were included in the "stop success" regressor, generating a contrast image for all available successful stop trials. For the CommonSSD and UncommonSSD condition, the "stop success" regressor was split into two distinct regressors according to the duration of the SSD as described above, generating contrast images for the CommonSSD trials and for the UncommonSSD trials, separately. For the AllSSD-subsample analysis, all successful stop trials were randomly separated to one of two regressors ensuring that the AllSSD-subsample regressor contained a similar number of trials as were represented in the CommonSSD regressor. For each SSD, the total number of successful stop trials completed at that given SSD length is plotted for each group. Notably, the superior inhibitors' distribution is shifted towards longer SSDs, and the poor inhibitors' distribution is shifted towards shorter SSDs. The shaded region represents the distribution of trials that were inhibited by both superior and poor inhibitors, and thus formed the subset of trials for the CommonSSD analysis. The non-shaded regions represent the trials that were uniquely inhibited by only one group, and thus formed the subsets of trials for the UncommonSSD analysis Number of successful stop trials at each SSD. The SSD is listed in milliseconds on the left panel of the table. For each SSD, the total number of successful stop trials for each group is listed from the AllSSD condition (Trials), along with the total number of participants that successfully inhibited at that delay (Participants). The italic bolded numbers represent the CommonSSD distribution of participants and trials that were taken from both groups for this analysis.
| Regions of interest generation
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| 5 first generated for stop success activity from all successful stop trials from all 210 participants. Regions were then selected by the ten peaks exhibiting the greatest activity for the stop success contrast, and spheres with a radius of 5 mm were centered on the ten local maxima. All ten regions were gray matter masked to remove white matter and CSF from the sphere. Marsbar ROI toolbox for SPM was used to extract the average percent signal change for voxels within each of the ten ROIs (marsbar.sourceforge.net). 
| R E SULTS

| Demographic and performance
Group means and standard deviations for demographic variables of the superior and poor inhibitors can be found in Table 2 . There were no significant differences in age (t (208) There was no significant difference between superior and poor inhibitors on average reaction times from successful go trials (t(208) 5 1.03, p 5 .3).
| AllSSD fMRI
First, superior and poor inhibitors were compared using activity derived from all successful stop trials across the ten regions of interest.
Univariate analysis of covariance (ANCOVA) was used to compare the two groups, and age, sex, handedness, scan acquisition site and percentage of stop trials successfully inhibited were used as covariates in the model (all results held if the percentage of successful stop trials was not included as a covariate). Given that group differences were tested at ten regions functionally defined by the same task contrast and are not completely independent of one another, we employed a modified Bonferroni adjustment accounting for the average correlation of stop success activity across the ten ROIs (r 5 .38; Bender & Lange, 2001 ). This resulted in a corrected significance threshold of p < .012.
Superior inhibitors displayed significantly greater stop success activity compared to poor inhibitors in the right IFG/anterior insula (F (197) 5 12.28, p < .005) and right temporal (F(197) 5 11.02, p < .005) ROIs (Figure 4 ). In the right occipital ROI, the results suggest superior inhibitors exhibit greater stop success activity than poor inhibitors, however the difference did not pass the corrected statistical threshold (p 5 .048).
| CommonSSD and UncommonSSD fMRI
A 2 3 2 mixed effects analysis of covariance (ANCOVA) was run using trial subset as the within-subject variable (CommonSSD and Uncommon SSD), group as the between-subject variable (superior and poor inhibitors), and age, sex, handedness, scan acquisition site, and 
| Post hoc separation of IFG and insula
To separate effects in the right and left inferior frontal gyri from effects in the right and left anterior insula, superior and poor inhibitors were compared in the AllSSD analysis and Common/UncommonSSD 3 group interaction in the four regions created post hoc (See Figure 3) . In Error bars are plotted for 6 1 standard error. Bonferroni adjusted thresholds accounting for average correlation across the ten regions of interest were calculated separately for the CommonSSD (p < .014) and UncommonSSD (p < .016) analyses. An * denotes group differences that surpass the Bonferroni-corrected thresholds, and † is used to denote p values that are less than .05 but do not pass Bonferronicorrected thresholds. ⌘ is used to indicate an interaction between group and analysis condition (CommonSSD vs. UncommonSSD). In regions showing significant interactions, the following effect sizes were calculated for post hoc group differences in the CommonSSD and UncommonSSD analyses. CommonSSD: right IFG/anterior insula h p 2 5 0.015; right occipital h p 2 5 0.000; left occipital h p 2 5 0.000; left 
| D ISCUSSION
The current study examined the influence of the adaptive algorithm in the Stop Signal Task when measuring inter-individual differences in stop-related activity. The adaptive SST has particular strengths for inhibitory control research in that it allows for easy calculation of a measure of the speed of inhibitory processes (i.e., the SSRT) and it ensures all participants are inhibiting at an equal inhibition rate (50% of stop trials). However, the cause for concern raised in this report is that it achieves the latter by creating an objectively more difficult version of the task for superior inhibitors. Consequently, these differences in task difficulty may contribute to the greater stop-related activity seen in superior inhibitors and in healthy controls when compared to clinical participants.
The present results suggest that comparing superior and poor inhibitors on trials matched for objective difficulty (i.e., trial SSD) yields different results than comparing the groups on trials matched for inhibition rate performance (i.e., subjective task difficulty). In the AllSSD condition (equal subjective difficulty), superior inhibitors displayed greater activity than poor inhibitors in the right IFG/anterior insula and the right temporal regions of interest. In the CommonSSD condition (equal objective difficulty) these effects did not survive correction for multiple comparisons. Furthermore, results from the AllSSD-subsample condition matched those from the AllSSD condition, suggesting the attenuation of group differences observed in the CommonSSD condition is not a result of the reduction in the number of trials (i.e., loss of statistical power) used to generate stop-related activity.
In the right IFG/anterior insula, the right occipital, the left occipital, the left IPL, the right temporal, and the left DLPFC, there were significant interactions between condition (CommonSSD vs. UncommonSSD) and group. If difficulty to inhibit increases as SSD increases, then the UncommonSSD condition reflects the largest group difference in objective task difficulty, being composed of the shortest SSD trials from the poor inhibitors and the longest SSD trials from the superior inhibitors.
As seen in Figure 5 , post hoc analyses of these interactions show these regions of interest exhibit larger group differences in the UncommonSSD condition compared to the CommonSSD condition. Combined with the main effects of the AllSSD and CommonSSD analyses, these results support the hypothesis that differences in objective task difficulty inflate group differences in stop-related activity. That said, it should be noted that the subthreshold effects observed in the CommonSSD condition and the pattern of effects in Figure 5 show the influence of task difficulty to be largely quantitative in nature.
Although the focus of the current study was to examine the influ- The findings from the AllSSD analysis replicate previous neuroimaging work on the SST demonstrating that superior performance on the task is associated with increased neural activity (Aron & Poldrack, 2006; Chikazoe et al., 2009; Chao et al., 2009; Congdon et al., 2010; Duann et al., 2009; Li et al., 2006; Li et al., 2008; Whelan et al., 2012) .
However, these studies have failed to acknowledge the potential influence of SSD length, and therein objective task difficulty. Thus, the current report is, to our knowledge, the first to show that group differences in neural activity are diminished when controlling for objective task difficulty in the Stop Signal Task.
Although the present results suggest that objective task difficulty influences stop-related activity, the AllSSD analysis, which includes all trials and is standard in the literature, should still be considered a valuable probe of individual differences in inhibitory ability. Rather than interpreting the increased activation level of a superior inhibitor as indicating that they necessarily activate more when inhibiting, we suggest instead that it reveals the increased activation "capacity" that the superior inhibitor has. The adaptive SST successfully reveals the superior ability of this participant (faster SSRT and longer successfully inhibited SSD) and the increased levels of activity that they can achieve. The corollary is that it is not the case that the superior inhibitor must activate more in order to successfully inhibit (once the influence of task difficulty is accommodated). Previous work has found similar effects in tasks of working memory and proactive response inhibition. Specifically, Schneider-Garces and colleagues (2010) found that on a working memory task in which young adults outperform a group of elderly participants, young adults showed an increase in neural activity as task demands increased, whereas elderly participants did not show this increase. Similarly, a study examining the Go/No-Go task found that adults, but not children, were able to increase activation in ventral prefrontal regions as interference increased from additional go trials (Durston et al., 2002) . Although the current study cannot interpret results from a developmental framework as the two aforementioned reports do, the results here also suggest superior task ability is associated with an increased capacity for activation as objective task demands increase.
The results from the current study suggest a caveat when interpreting group difference in activation in the presence of performance differences, as is often the case when contrasting a clinical group against controls. If activation differences are related, in part, to the differences in task difficulty that arise from differences in inhibitory ability then the magnitude of those activation differences are will be affected by the SSD effects described here. The degree to which groups differ on stop-related activity will be related to the degree to which those groups differ on the distribution of successful stop signal delays. Thus, the magnitude of group differences in activation will reflect a combination of both inherent difference in the ability to activate per se and the task difficulty effect. Arising from this conclusion, the authors propose the following recommendations for future research. First, if researchers wish to account for the influence of objective task difficulty on stoprelated BOLD activity, then the research design might employ the "CommonSSD" analysis approach used here. Second, for research continuing to use the standard "AllSSD" analysis, we offer a nuanced interpretation of individual differences in stop-related BOLD activity. That is, individual differences in inhibitory ability are reflective of a greater capacity for activation as the objective difficulty to inhibit a response increases. Thus, superior inhibitors do not activate the STOP network more than poor inhibitors if the two are compared on trials of similar objective task difficulty (i.e. SSD). However, the superior ability of the former group is demonstrated by their ability to perform more difficult trials yielding greater levels of activation. This interpretation offers insight into the neurobiological mechanisms that characterize individual differences in inhibitory control.
| C ONC LUSI ON
While the SST retains very many strengths, we suggest that interpretations of individual or group differences in activation should be cogni- 
